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Abstract
Background: Since its inception, evidence-based medicine and its application through systematic reviews, has been 
widely accepted. However, it has also been strongly criticised and resisted by some academic groups and clinicians. 
One of the main criticisms of evidence-based medicine is that it appears to claim to have unique access to absolute 
scientific truth and thus devalues and replaces other types of knowledge sources.
Discussion: The various types of clinical knowledge sources are categorised on the basis of Kant's categories of 
knowledge acquisition, as being either 'analytic' or 'synthetic'. It is shown that these categories do not act in opposition 
but rather, depend upon each other. The unity of analysis and synthesis in knowledge acquisition is demonstrated 
during the process of systematic reviewing of clinical trials. Systematic reviews constitute comprehensive synthesis of 
clinical knowledge but depend upon plausible, analytical hypothesis development for the trials reviewed. The dangers 
of systematic error regarding the internal validity of acquired knowledge are highlighted on the basis of empirical 
evidence. It has been shown that the systematic review process reduces systematic error, thus ensuring high internal 
validity. It is argued that this process does not exclude other types of knowledge sources. Instead, amongst these other 
types it functions as an integrated element during the acquisition of clinical knowledge.
Conclusions: The acquisition of clinical knowledge is based on interaction between analysis and synthesis. Systematic 
reviews provide the highest form of synthetic knowledge acquisition in terms of achieving internal validity of results. In 
that capacity it informs the analytic knowledge of the clinician but does not replace it.
Background
Systematic reviews, in healthcare, have been described as
providing objective overviews of all the evidence cur-
rently available on a particular topic of interest [1]. Such
overviews cover clinical trials in order to establish where
effects of healthcare are consistent and where they may
vary. This is achieved through the use of explicit, system-
atic methods aimed at limiting systematic error (bias) and
reducing the chance of effect [2]. Systematic reviews have
been recommended as providing the best source of evi-
dence to guide clinical decisions [3,4] and healthcare pol-
icy [5], and they receive twice as many citations as non-
systematic reviews in peer-reviewed journals [5-7]. Fur-
thermore, systematic reviews are increasingly utilized in
appraising the evidence regarding the cost-effectiveness
of interventions [8,9], the costs of guideline dissemina-
tion and implementation [10] or evidence from qualita-
tive studies [11].
The use of systematic reviews for the appraisal of clini-
cal studies has been introduced and promoted within the
framework of evidence-based medicine (EBM). Sackett et
al. recommended EBM as "the conscientious, explicit,
and judicious use of current best evidence in making
decisions about the care of individual patients" [12].
These authors defined the practice of evidence-based
medicine as "integrating individual clinical expertise with
the best available external clinical evidence from system-
atic research". They described best evidence as "clinically
relevant research, often from the basic sciences of medi-
cine, but especially from patient-centred clinical research
into the accuracy and precision of diagnostic tests
(including the clinical examination), the power of prog-
nostic markers, and the efficacy and safety of therapeutic,
rehabilitative, and preventive regimens" [12].
Since its inception, EBM has been widely accepted by
academia, healthcare funders and healthcare providers. It
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Page 2 of 7has also been strongly criticised and resisted by some
academic groups and clinicians. One of the main criti-
cisms of EBM is that it claims to have unique access to
absolute scientific truth, as gained for clinical therapy
through randomized control trials (RCT) and subsequent
systematic reviews of RCTs. The implication is that EBM
claims, on this basis, the ability to exercise judgement
(e.g. through appraisal of clinical studies during system-
atic reviews) and thus devalues and replaces knowledge
sources of other types [13].
The types of knowledge sources allegedly threatened by
EBM include: (i) the inferences of basic science used for
prediction of clinical outcomes [14]; (ii) clinical judge-
ment based on experience - often expressed in the form
of single case studies and narrative reviews [15,16]; (iii)
qualitative and observational research [16].
Further criticisms of EBM are that it produces popula-
tion-based research results which are not applicable to
individual patients and that research results from which
any confounder impact is eliminated (i.e. through ran-
domization and double blinding) can never wholly apply
to particular individual situations faced by clinicians in
their daily practice [15]. Critics of EBM argue that clinical
trials ignore knowledge gained from basic science, in
areas such as human physiology and diseases and phar-
macology, from which valuable information about the
effect of a particular drug or treatment can be inferred
[14]. They hold that clinical judgement based on experi-
ence is more exact, because of its emphasis on individual
cases rather than evidence derived from RCT [15]. As
RCTs provide average estimates with confidence intervals
from study groups instead of from single individual
patients, their results remain allegedly non-applicable to
daily clinical practice [15]. Therefore, it is argued, RCTs
lack the necessary illustration of nuances of treatment
that single-case reports provide [16]. Qualitative, as
opposed to quantitative research, is seen to provide in-
depth examination of small numbers of patients and is
able, unlike hypothesis-driven quantitative EBM
research, to provide information regarding the complex-
ity (including psychological and social aspects) of a dis-
ease [16]. Qualitative research, it is further argued, has
the capacity to explore the meanings that symptoms, con-
sultations and treatments have for a patient -- aspects
that EBM is accused of degrading or ignoring [16].
In response to such criticism, EBM promoters reply
that sole reliance on basic science without clinical testing
raises high uncertainties regarding treatment safety and
efficiency [14]. Such uncertainties are based on the limits
and incompleteness of basic scientific knowledge about
the human body and its interaction with the environment
[14]. In addition, it is reported that medical history con-
firms that therapeutic predictions based on sound basic
science have, in many cases, been proven wrong after
clinical testing [17]. One example is the well-cited case of
Flecainide, which was used for treating supraventricular
tachycardia. Only after clinical trials had been conducted
was it found that it actually increased mortality in
patients [18].
Reliance on clinical judgement based on experience can
be misleading, owing to the unrecognised play of chance
and the easy confusion of the natural history of the dis-
ease with the treatment effect [19]. For that reason,
patients often get better or worse on their own, notwith-
standing intervention [14]. A wide variation in clinicians'
judgment has been observed in a group of 819 doctors
from Australia and UK [20]. Only 55% correctly recog-
nized the risks for ischaemic heart disease and just 6.7%,
the risk of deep-vein-thrombosis. Traditional experience
can also be a poor judge of the efficacy of treatments such
as the widespread prophylactic removal of pathology-free
impacted third molars to prevent cysts and tumours,
resorption of second molars, caries and periodontal
problems. In contrast, a systematic review found no evi-
dence that this procedure offered clinical benefits [21].
Qualitative and observational study results are often
tainted by systematic error and thus, lack the necessary
internal validity that could allow any generalisation
beyond the studied cases [14]. In terms of the criticism
that EBM produces population-based research results
that are not applicable to individual patients, EBM pro-
moters respond that risks of disease, identified through
population-based research, remain applicable to individ-
ual subjects. Once a causality has been detected, such
causality will be as valid for individual patients in clinical
practice as it is for subjects in the studied groups/popula-
tions [15]. Moreover, elimination of confounders
through, for example, the randomization process in
RCTs, does not render data irrelevant to individuals.
Such data remains applicable to an individual patient, to
the extent to which the patient shares the characteristics
of the subjects studied in the RCT [22].
Against the background of such ongoing debate, this
article aims to present a philosophical proposition
regarding the acquisition of knowledge, which may help
to clarify the relationship between the epistemological
concepts that appear to underlie the different standpoints
of EBM critics and promoters. It also aims to show how
systematic reviews rely on the unity of analysis and syn-
thesis in the process.
Acquisition of knowledge
The German philosopher Immanuel Kant regarded expe-
rience as the direct encounter of a subject and an object,
and knowledge as the judgment of such encounter
[23,24]. Reflective judgment of experience could be either
'analytic' or 'synthetic'. While an analytic reflective judg-
ment only asserts logical relations between concepts, a
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real relationships between concepts and objects. There-
fore, an analytical judgment of an experience recognises
truth by virtue of conceptual meanings only, without
depending further on external facts. An example of an
analytical judgment is the statement: "Yellow is a colour".
We know that this statement is correct. No additional
evidence is needed because we know the meanings of the
words "yellow" and "colour" [23,24].
In contrast, a synthetic judgment of experience recogn-
ises truth by virtue of conceptual meanings and external
facts. Here, an example is the statement: "This table is
yellow." Although we understand the meanings of the
words "table" and "yellow", we still need to check whether
the table is indeed yellow, thus requiring further evidence
in order to accept that this statement is true [23,24].
The scientific method of analysis employs analytical
reflective judgment. Analysis, according to the classical
definition by Leipnitz, is a "process in which we begin
with a given conclusion and seek principles by which we
may demonstrate this conclusion" [25,26]. This means
that causes are inferred from effects through assertion of
logical relations between the two concepts and their rela-
tionship is used to develop plausible hypotheses [25,26].
During this process, care is taken to ensure that the
resulting hypothesis does not contradict already existing
knowledge. In clinical praxis this would mean that a doc-
tor examines a patient, discovers symptoms and, on the
basis of these and knowledge acquired from basic science
and personal clinical experience, infers (diagnoses) a spe-
cific disease as the possible cause of such symptoms
(effect). Similarly, in scientific research a possible/plausi-
ble hypothesis that could explain observations in line
with current knowledge may be developed. However, a
plausible hypothesis does not necessarily provide actual
proof. Such proof may be found through the scientific
method of synthesis. The classical definition of synthesis
is "a process in which we begin from principles (= Cause)
and proceed to build up conclusions" (= Effect) [25,26].
However, this is really only an inverted definition of anal-
ysis. It does not consider the need for outside facts and is
thus limited to the inference of effects from known
causes, (i.e. by inductive reasoning through Analogy or
Teleology [25,27] in line with existing knowledge). The
solution for this type of problem can be found in the work
of Johann Gottlieb Fichte (often wrongly ascribed to
Hegel). He defined synthesis as a result of the dialectic
interaction/conflict between 'thesis' and 'antithesis' [28].
'Thesis' represents a formulated idea or concept that can
be, for example, an hypothesis developed through analy-
sis. This hypothesis is then engaged by an opposing con-
cept or fact, or external conditions that are not part of the
initial hypothesis, created through experiment, scientific
trial or other observations: the antithesis. Through this
interaction/conflict, truths contained in the thesis and
antithesis are reconciled at a higher level, thus forming
synthesis. In turn, this synthesis constitutes a new thesis
that is opposed by a new antithesis in a continuous pro-
cess. Reflective judgement of the thesis in relation to the
antithesis asserts real relationships between concepts and
objects. Therefore, synthetic reflective judgment [23,24]
is employed during the process of synthesis by thesis/
antithesis [28]. One example is the 'extension for preven-
tion' concept mentioned by GV Black (= Thesis) in rela-
tion to operative dentistry. It deals with the need to
remove carious tooth tissue before restoring a tooth with
amalgam, in order to prevent further caries progression
[29]. An antithesis to this concept is the observation by
Mertz-Fairhurst et al. that caries, after the sealing of
retained carious tooth tissue, only progresses very slowly
[30]. Frencken et al. reached a synthesis of both views, by
introducing the atraumatic restorative treatment (ART)
approach, on the basis of selective caries removal [31].
Selective caries removal according to the ART approach
relies upon the removal of infected, soft tooth tissue,
using only hand instruments. Affected, remineralisable
carious tooth tissue is left behind and sealed with a bio-
mimetic material. A recent systematic review with meta-
analysis showed ART restorations to be clinically as suc-
cessful as amalgam restorations placed according to GV
Black's 'extension for prevention' concept [32]. Following
Fichte's dialectic view of synthesis, scientists try to test
the veracity of existing hypotheses through, for example,
conducting clinical trials [27]. In this case, a null-hypoth-
esis would form the thesis and the trial conditions, its
antithesis. The result would be the synthesis in the form
of rejection or acceptance of the null-hypothesis.
In this context the inference, extrapolation (projection
from basic science) and application of clinical judgement
based on experience are analytic; while synthesis is repre-
sented in the conduct of clinical case studies, qualitative-,
observational- and randomized control trials, and in sys-
tematic reviews with meta-analysis.
Systematic error
Systematic error constitutes any factor in the knowledge
acquisition process that systematically diverts its out-
comes away from true values [33]. Systematic error,
therefore, limits the internal validity of acquired knowl-
edge. Internal validity depends upon the linking together,
apart from random error, of an inferred or investigated
cause and effect; thus ensuring causality [34]. With
regard to analytic knowledge acquisition, the problems of
(i) inferring from basic science and (ii) applying clinical
judgement based on experience alone have been high-
lighted above [14,17]. With regard to synthetic knowl-
edge acquisition, a range of systematic errors has been
identified: selection-, performance-/detection-, and attri-
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error on clinical trials, the methodological interventions:
randomization (random sequence allocation and alloca-
tion concealment), blinding and intention-to-treat analy-
sis have been proposed for each type of bias, respectively
[34].
Empirical evidence from meta-epidemiological studies
indicates that without the application of methodological
bias-controlling measures in clinical trials, a systematic
error effect may manifest itself in the form of a substan-
tial over-estimation of results. Trials that investigate sub-
jective outcome measures are especially at risk. The level
of over-estimation associated with attrition bias (lack of
intention-to-treat analysis) can reach up to 25% [35]. The
lack of adequate randomization (through sequence allo-
cation and allocation concealment) and blinding (thus
minimizing Selection- and Performance-/Detection bias,
respectively) may reach above 50% [36]. This means that
if a study claims a 20% lower relative risk (RR 0.80) for a
new treatment, as compared to a control under a condi-
tion of a 50% overestimation, the actual result of the
observed treatment effect would be a 20% increased risk
(RR 1.20) for the patient. Thus, it would be the complete
opposite of the initial claim. Such high percentages of
over-estimation due to bias may therefore lead to situa-
tions where ineffective treatment procedures are pre-
sented as effective.
The empirical evidence regarding the danger of system-
atic error suggests that inclusion of bias-controlling mea-
sures; such as randomization, blinding and attrition
control, into the study design of clinical trials is justified.
It also provides the justification for judging the internal
validity of clinical trials according to how well bias-con-
trolling measures are implemented in their study designs;
i.e. in line with an evidence-hierarchy [37]. Assessment of
clinical trials according to their internal validity is part of
the systematic review process.
Systematic review
Systematic reviews are defined, according to the
Cochrane collaboration, as scientific literature reviews
aimed at answering clearly formulated questions by use of
systematic and explicit methods for identifying, selecting,
and critically appraising relevant research, and for col-
lecting and analysing data from the literature included in
the review [38]. During a systematic review, meta-analy-
sis may be used as a statistical tool for analysing and sum-
marising the results of the included studies [39]. In order
to fulfil this function, a systematic review should: (i) pres-
ent a synthesis of the acquired knowledge regarding one
particular clinical question derived from all relevant stud-
ies that are identifiable at one point in time, (ii) identify
the level of internal validity and the subsequent potential
systematic error risk associated with the acquired knowl-
edge and (iii) provide recommendations for improving
any identified shortcoming related to internal validity, for
further research. Owing to continued further research,
systematic reviews should also provide continued
updates of their synthesis.
In order to achieve its objectives, a systematic review
includes (i) a systematic search for studies from all known
and relevant information sources; (ii) the selection of
studies with highest internal validity -- or if not many
studies can be found, the sub-grouping of available trials
in line with their various internal validity strengths; (iii)
quality assessment of studies in line with internal validity
criteria and, if possible, (iv) meta-analysis of the com-
bined study data.
Through this process, systematic reviews provide the
most comprehensive answers to clinical questions, with
least possible systematic error. Such high internal validity
provides a basis for the external validity of results. Exter-
nal validity describes how well results can be generalised
and are applicable to other circumstances [34]. Evidence
that is free of systematic error appears to be more likely
to remain correct, even under changing circumstances,
than results that carry a high risk of over-estimation.
However, although external validity can only be possible
on the basis of good internal validity [34], good internal
validity of evidence from systematic reviews on its own
has been shown to provide no absolute guarantee of good
external validity. A case study [40], during which the con-
duct and management of a systematic review of studies
concerning interventions for reducing substance misuse
in young children was observed, noted the exclusion of
review articles that did not follow a systematic methodol-
ogy but contained explicit considerations of wider envi-
ronmental factors impacting upon substance misuse.
This study reported that the subsequent guideline devel-
opment process resolved to ad-hoc inferences regarding
the application of the systematic review results, due to its
lack of external validity focus [40]. Apart from future sys-
tematic reviews with more emphasis on categories of
external validity, qualitative research may add important
information regarding the external validity of evidence,
by investigating the complexity of, for example, the psy-
chological and social aspects of disease [16]. Single case
reports may indeed provide the necessary illustration of
nuances during the judicious use of current best evidence
[16]. For example, a case report [41] that informed on
aspects of implementation and patients' response to
atraumatic restorative treatment (ART) in an oral health-
care service provided important insights concerning the
external validity of ART results that were established
through a relevant systematic review [33]. Through sys-
tematic reviews focussing on high internal validity, ana-
lytical clinical judgment becomes more informed [12].
This implies that synthesis informs analysis and is not in
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and critics seems to suggest. Instead, both analysis and
synthesis exist in unity.
Analysis and synthesis unity
The unity of analysis and synthesis is demonstrated in the
suggested model (Figure 1). Analytical knowledge derived
through projection from basic science, as well as from
experiences, forms the basis for a plausible hypothesis
(H). It has been suggested that any empirical test results
are meaningless if the tested hypothesis violates princi-
ples of basic science [14]. For example, evidence from
RCTs supporting the claim of homeopathic remedies to
be effective beyond the placebo effect would be seriously
doubted, as knowledge derived from basic science does
not provide an explanation of how highly diluted homeo-
pathic solutions can contain any active ingredient capable
of causing any observed significant (p < 0.05) treatment
effect [42]. This implies that analysis justifies synthesis.
Therefore, as shown above on hand of a plausible hypoth-
esis development [25], sources of "other knowledge" on
an analytical basis are extremely important in hypothesis
development (HD).
The development of a plausible hypothesis needs to be
followed by hypothesis testing (HT). Such testing has to
take into consideration the empirical evidence [35,36] for
the negative impact of systematic error. This requires a
focus on inclusion into the study design of clinical trials,
of bias-controlling measures: randomization, blinding
and attrition control. Results of clinical trials that utilize
such measures, like RCTs can therefore be considered to
have higher internal validity in terms of hypothesis test-
ing. Synthesis by trial is obtained through engagement of
the hypothesis (= Thesis) with the rigor of the clinical
trial methodology (= Antithesis). However, the knowl-
edge acquired through synthesis by one single trial stands
isolated from the results of other trials with similar focus.
A systematic review with meta-analysis achieves unifica-
tion of isolated trial results and thus, can provide a more
comprehensive answer to clinical questions than one sin-
gle trial can. For example, the pooled results of one meta-
analysis that included 31 randomized control trials indi-
cated a reduction of risk of recurrence of breast cancer
after chemotherapy, in contrast to no chemotherapy,
while the individual result of each trial was inconclusive
[43]. The synthesis from systematic reviews that include
meta-analysis is based (in direct proportion to the sample
size of each trial) on the weighted comparison between
combined data of conventional treatments as control (=
Thesis), with the combined data of newly developed (test-
) interventions (= Antithesis). During this process bias-
controlling measures, such as the selection of trials with
high internal validity (e.g. RCT for therapy related topics),
and quality assessment of trials, are utilized.
Through synthesis by systematic review, a comprehen-
sive answer to clinical questions is achieved, with least
possible systematic error and with high internal validity.
On this basis, the analytic knowledge of the clinician is
informed. According to a model by Glaszion and Irwig
[44], systematic review results of RCTs would provide a
doctor with, for example, information about the net ben-
efit of Warfarin treatment for a patient with fibrillation
and the risk of thromboembolic stroke. A systematic
review of cohort studies would provide information
regarding the potential harm of such treatment (e.g.
induction of intracranial bleeding by Warfarin). This evi-
dence would also reveal that the benefit of Warfarin
increases along with the increase in risk for thromboem-
bolic stroke and that the danger of for example, bleeding,
remains constant. Armed with such information, the doc-
tor would examine his patient for signs of major risk fac-
tors such as high blood pressure or previous
thromboembolism. The doctor could then, on the basis
of the evidence, be able to judge that in absence of any
major risk factors, the benefit of Warfarin treatment
would be outweighed by its potential harm and might
thus decide against treating the patient with Warfarin.
From this process new analytical knowledge is formed
and clinical judgment altered and updated and, in time,
clinical experience on a higher level of acquired knowl-
edge is developed. Such clinical experience in turn pro-
vides the analytical basis for future hypothesis
development in line with basic science, thus forming a
repeated interaction between analysis and synthesis. The
repeated interaction results in the continued acquisition
of clinical knowledge on higher levels over time.
The acquisition of clinical knowledge is based on the
interaction between analysis and synthesis. It is errone-
ous to judge one as being superior to the other. System-
atic reviews provide the highest form of synthetic
Figure 1 Analysis, Synthesis unity. HD = Hypothesis development. 
HT = Hypothesis testing
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validity of results. However, this should not imply that
systematic reviews are generally superior to other forms
of knowledge or can replace, for example, the function of
qualitative research results, particularly in relation to
aspects of external validity and clinical judgment regard-
ing the care of individual patients. On the other hand,
analytical clinical judgment that is not informed by high
internal validity synthesis becomes in time obsolete for
patient treatment and faces the danger of being affected
by systematic error.
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